Allergan plc and Pfizer Inc. have confirmed they’re exploring a possible combination. Dublin, Ireland-based Allergan released a statement Thursday saying it’s in early talks with Pfizer about a possible deal, and Pfizer later affirmed Allergan’s statement.
The staff of the Federal Trade Commission has submitted comment for the Food and Drug Administration’s draft guidance on nonproprietary names for biological products.
Aurobindo Pharma Ltd. has received final approval from the Food and Drug Administration for tramadol hydrochloride extended-release tablets, an opioid pain medication (Class IV), in dosages of 100 mg, 200 mg and 300 mg.
The EQuIPP platform for measuring pharmacy performance has reached a milestone. Pharmacy Quality Solutions Inc. (PQS) said Monday that EQuIPP — to which 90% of U.S.
Endo Pharmaceuticals Inc. and BioDelivery Sciences International Inc. have gained approval from the Food and Drug Administration for Belbuca buccal film (buprenorphine), an opioid treatment for chronic pain.
Pharmacies offering appointment-based medication synchronization (ABMS) can improve patients’ adherence to their prescriptions and, in turn, produce better health outcomes, a study conducted for the National Community Pharmacists Association and Arkansas Pharmacists Association finds.
Procter & Gamble veteran Dennis Curran has joined GlaxoSmithKline Consumer Healthcare as U.S. vice president of sales and chief customer officer.
Slow growth is foreseen for health insurance enrollment through the Affordable Care Act exchanges, the Obama administration said this month. Coverage by the end of 2016 will barely exceed current levels, the administration said.
Amneal Pharmaceuticals won the award for “Company of the Year, Americas” at the 2015 Global Generics and Biosimilars Awards held in Madrid, Spain.
The pharmacy industry is doing its part to help stem the tide of prescription drug abuse and heroin use as part of wide-ranging, public- and private-sector efforts announced this week by President Barack Obama. At a community forum in Charleston, W.Va.
Impax Laboratories Inc. has received approval from the Food and Drug Administration for guanfacine extended-release tablets, a treatment for attention deficit hyperactivity disorder (ADHD).
For a congressional hearing on medication therapy management, the National Association of Chain Drug Stores emphasized the value of pharmacists in providing MTM services, especially in improving medication adherence, patient health and health care affordability for Medicare patients.
Chain drug retailers have begun extensive outreach programs to provide consumers with access to information and resources for Medicare Part D and Health Insurance Marketplace coverage options. Medicare Part D annual enrollment began Oct. 15 and runs through Dec. 7.
Teva Pharmaceutical Industries Ltd. has released dutasteride capsules 0.5 mg, a medication for enlarged prostate, in the United States.
The National Community Pharmacists Association is working with U.S. Department of Health and Human Services (HHS) to help spur enrollment in health insurance plans.
Congressional support continues to mount for the pharmacy industry’s push for pharmacists to be designated as health care providers. The American Pharmacists Association (APhA) reported that a majority of the U.S.
